|
| << previous | next >> |
Journal description
All volumes of the corresponding journal
All issues of the corresponding volume
All articles of the corresponding issues
Details for article 6 of 17 found articles
| Title: |
Cusatuzumab plus azacitidine in newly diagnosed acute myeloid leukaemia ineligible for intensive chemotherapy (CULMINATE): part one of a randomised, phase 2, dose optimisation study |
| Author: |
Pabst, Thomas Papayannidis, Cristina Demirkan, Fatih Doronin, Vadim Fogliatto, Laura M Guttke, Christina Gyan, Emmanuel Hamad, Nada Herrera, Pilar Hultberg, Anna Jacobs, Julie Johnson, Amy J Langlois, Angélique Ma, Xuewen Martinelli, Giovanni Arnan, Montserrat Müller, Rouven Nottage, Kerri Ofran, Yishai Özcan, Muhit Samoilova, Olga Tolbert, Jaszianne A Trudel, Géralyn C Xiu, Liang Vey, Norbert Wei, Andrew H |
| Appeared in: |
The Lancet. Haematology |
| Paging: | Volume 10 () nr. 11 pages e902-e912 |
| Year: |
2023 |
| Contents: | |
| Publisher: |
Elsevier Ltd |
| Source file: |
Elektronische Wetenschappelijke Tijdschriften |
Details for article 6 of 17 found articles
| << previous | next >> |